title: Philadelphia chromosome-positive acute lymphoblastic leukemia.
abstract: The Philadelphia (Ph1) chromosome, ubiquitous in chronic myelogenous leukemia, also is commonly seen in acute lymphoblastic leukemia, particularly in adults. Whereas the presence of the Ph1 chromosome is associated with high white blood cell count and older age, the Ph1 chromosome is known to be an independent poor prognostic factor. Most Ph1+ patients are able to achieve remissions with intensive, systemic chemotherapy, but treatment is complicated by early relapse. Because of the uniformly poor prognosis and response to therapy in childhood and adult Ph1+ acute lymphoblastic leukemia, aggressive and investigational therapies should be considered early in the course of this disease.
authors.affiliation: Department of Medicine, University of Chicago, Pritzker School of Medicine, Illinois.
authors.forename: T M
authors.initials: TM
authors.lastname: Lestingi
authors.forename: A L
authors.initials: AL
authors.lastname: Hooberman
mesh_terms: D000328:Adult; D000367:Age Factors; D000951:Antigens, Neoplasm / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D016026:Bone Marrow Transplantation; D002648:Child; D003582:Cytogenetics / Q000379:methods; D016044:Fusion Proteins, bcr-abl / Q000032:analysis; D015321:Gene Rearrangement; D006801:Humans; D015994:Incidence; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D011379:Prognosis; D012074:Remission Induction
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D016044:Fusion Proteins, bcr-abl